Last update 18 Apr 2026

RGT-274-CR

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
RGT-274-CR
Target
GLP-1R
Action
agonists
Mechanism
GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
ObesityDiabetes Mellitus, Type 2
Inactive Indication-
Originator Organization
Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.
Active Organization
Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with RGT-274-CR
CTR20252290
/ RecruitingPhase 1
一项在中国受试者中进行的RGT-274-CR胶囊单次、多次给药的安全性、耐受性、药代动力学及药效学研究
[Translation] A study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of RGT-274-CR capsules in Chinese subjects
CTR20261326
/ Not yet recruitingPhase 2
一项在肥胖参与者中评价RGT-274-CR胶囊的有效性和安全性的多中心、随机、双盲、安慰剂对照的Ⅱ期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial evaluating the efficacy and safety of RGT-274-CR capsules in obese participants.
100 Clinical Results associated with RGT-274-CR
Login to view more data
100 Translational Medicine associated with RGT-274-CR
Login to view more data
100 Patents (Medical) associated with RGT-274-CR
Login to view more data
100 Deals associated with RGT-274-CR
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ObesityPhase 2
China
Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.
09 Apr 2026
Diabetes Mellitus, Type 2IND Approval
China
Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.
03 Mar 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free